158 related articles for article (PubMed ID: 34627500)
1. WHO Essential Medicines Committee spotlights unaffordable drugs.
Furlow B
Lancet Oncol; 2021 Nov; 22(11):1503. PubMed ID: 34627500
[No Abstract] [Full Text] [Related]
2. Evaluating essential medicines for treating childhood cancers: availability, price and affordability study in Ghana.
Mensah KB; Mensah ABB; Bangalee V; Padayachee N; Oosthuizen F
BMC Cancer; 2021 Jun; 21(1):683. PubMed ID: 34112117
[TBL] [Abstract][Full Text] [Related]
3. Increasing access to quality anticancer medicines in low- and middle-income countries: the experience of Uganda.
Osinde G; Niyonzima N; Mulema V; Kyambadde D; Mulumba Y; Obayo S; Anecho E; Watera S; Constance M; Kadhumbula S; Orem J
Future Oncol; 2021 Jul; 17(21):2735-2745. PubMed ID: 33855863
[TBL] [Abstract][Full Text] [Related]
4. Patient access schemes for high-cost cancer medicines.
Williamson S
Lancet Oncol; 2010 Feb; 11(2):111-2. PubMed ID: 20152762
[No Abstract] [Full Text] [Related]
5. Can we achieve affordable cancer medicine prices? Developing a pathway for change.
Vogler S
Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):321-325. PubMed ID: 33653228
[No Abstract] [Full Text] [Related]
6. Access to essential medications for HIV/AIDS in South Africa.
Andrews S
S Afr Med J; 2001 May; 91(5):384-7. PubMed ID: 11455797
[No Abstract] [Full Text] [Related]
7. WHO includes 16 new cancer drugs on list of essential medicines.
Mayor S
Lancet Oncol; 2015 Jul; 16(7):757. PubMed ID: 26004373
[No Abstract] [Full Text] [Related]
8. Access to Antihypertensive Drugs in China.
Bai G; Bennet C; Wang J; Anderson GF
Circulation; 2018 Oct; 138(17):1777-1779. PubMed ID: 30354658
[No Abstract] [Full Text] [Related]
9. THE MOST FAVORED NATIONS MODEL INTERIM FINAL RULE IS FATALLY FLAWED AND MUST BE RESCINDED-YET THE PROBLEM IT ADDRESSES DEMANDS A SOLUTION.
Rubinstein E
J Manag Care Spec Pharm; 2021 Feb; 27(2):286. PubMed ID: 33506733
[No Abstract] [Full Text] [Related]
10. Essential medicines for hepatitis C: at what price?
Balakrishnan VS
Lancet Infect Dis; 2017 Sep; 17(9):904-905. PubMed ID: 28845797
[No Abstract] [Full Text] [Related]
11. Approaches to improving access to essential cancer medicines in the WHO South-East Asia Region.
Chivukula MV; Tisocki K
WHO South East Asia J Public Health; 2018 Sep; 7(2):62-66. PubMed ID: 30136662
[TBL] [Abstract][Full Text] [Related]
12. Drugs are scarce as mix of programs aims to ease access.
Brower V
J Natl Cancer Inst; 2009 Oct; 101(19):1304-6. PubMed ID: 19755680
[No Abstract] [Full Text] [Related]
13. Essential medicines for universal health coverage.
Wirtz VJ; Hogerzeil HV; Gray AL; Bigdeli M; de Joncheere CP; Ewen MA; Gyansa-Lutterodt M; Jing S; Luiza VL; Mbindyo RM; Möller H; Moucheraud C; Pécoul B; Rägo L; Rashidian A; Ross-Degnan D; Stephens PN; Teerawattananon Y; 't Hoen EF; Wagner AK; Yadav P; Reich MR
Lancet; 2017 Jan; 389(10067):403-476. PubMed ID: 27832874
[No Abstract] [Full Text] [Related]
14. Perspectives on Cost and Value in Cancer Care.
Saltz LB
JAMA Oncol; 2016 Jan; 2(1):19-21. PubMed ID: 26501848
[No Abstract] [Full Text] [Related]
15. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.
Zhu Y; Wang Y; Sun X; Li X
Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326
[TBL] [Abstract][Full Text] [Related]
16. Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care?
Zafar SY; Peppercorn JM
J Clin Oncol; 2017 Jul; 35(19):2113-2116. PubMed ID: 28459612
[No Abstract] [Full Text] [Related]
17. Having "Skin in the Game" and Allowing Cross-Border Importation of Drugs to Lower High Prices of Cancer Drugs.
Kantarjian H; Mathisen MS; Lipton JH
JAMA Oncol; 2015 Sep; 1(6):729-30. PubMed ID: 26182331
[No Abstract] [Full Text] [Related]
18. Improving affordability of new Essential Cancer Medicines.
't Hoen E; Meyer S; Durisch P; Bannenberg W; Perehudoff K; Reed T; Barber MJ
Lancet Oncol; 2019 Aug; 20(8):1052-1054. PubMed ID: 31303433
[No Abstract] [Full Text] [Related]
19. Health policy: Putting a price on cancer.
Sullivan R; Aggarwal A
Nat Rev Clin Oncol; 2016 Mar; 13(3):137-8. PubMed ID: 26856742
[No Abstract] [Full Text] [Related]
20. Reforming the World Health Organization's Essential Medicines List: Essential but Unaffordable.
Hwang TJ; Kesselheim AS; Vokinger KN
JAMA; 2022 Nov; 328(18):1807-1808. PubMed ID: 36279114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
